Project Grant HT94252410785
Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $320K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
- The Johns Hopkins University was awarded a $980,943 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into PAAN/MIF nuclease inhibition for neuroprotection in multiple sclerosis from August 15, 2022 to August 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...
- The Johns Hopkins University received a $248,356 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiometabolic Comorbidity and Outcomes in Multiple Sclerosis: A Polygenic Risk Score Approach". The award period runs from September 1, 2023 to August 31, 2025. The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research....
- The Johns Hopkins University was awarded a $320,165 project grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective October 1, 2025 through September 30, 2027. The award supports research investigating the relationship between social determinants of health, biological aging, and disease progression in multiple sclerosis (MS). This research is conducted at the institution's Baltimore, Maryland location and aligns with the Defense...
- Federal Grant Award Summary The Johns Hopkins University received a $318,483 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2027. The award funds research titled "Quantitative Measurement of Acute and Chronic Lesion Activity in a Real-World Multisite Clinical MRI Dataset," which aims to develop quantitative methodologies for analyzing magnetic resonance imaging (MRI)...
- The Johns Hopkins University was awarded a $982,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund preclinical studies of Bryostatin-1 to promote remyelination and repair in multiple sclerosis from July 15, 2021 to July 14, 2024. Through this funding, The Johns Hopkins University will investigate medical solutions for the battlefield by conducting applied and advanced biomedical research into...
- This $867,712 Project Grant award from the Department of the Army Medical Command (under the Military Medical Research and Development program, CFDA 12.420) supports advanced biomedical research at The Johns Hopkins University focused on transforming healthcare for military service members and the general public. The research aims to investigate effective treatment of pancreatic cancer through systemic chemotherapy combined with alpha-particle radiotherapy, with a focus on early hepatic...
- The Defense Health Agency (DHA) awarded The Johns Hopkins University a $616,150 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The BOLSTER (Blast-Exposure Outcomes and Associated Long-Term Symptom Trajectories Related to Essential Recovery-Pathways) Biomarker Initiative supports biomedical research designed to advance healthcare solutions for military service members. This three-year research...
- The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
- Federal Project Grant Award Summary The Johns Hopkins University received a $319,240 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2027. The research project, titled "Characterization of MicroRNAs Involved in Regulating Human Oligodendrocyte Maturation and Myelin Formation," will be conducted at the institution's Baltimore, Maryland location. This...
- This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $855,728 to The Johns Hopkins University to identify abnormally regulated lipid pathways in human motor neuron and fly models, with the goal of developing a new pharmacological drug candidate. The award period runs from Sep 1, 2024 to Aug 31, 2026. As a leading research university, Johns Hopkins has a strong track record of federal grant...
The Department of the Army Medical Command awarded a $319,938 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Johns Hopkins University. The grant, with a performance period from September 1, 2024 to August 31, 2026, will fund a large-scale MRI-based study to determine multiple sclerosis-specific atrophy phenotypes. This research aims to transform healthcare for military service members and the broader public by advancing the understanding and treatment of neurological conditions relevant to the military population. As a leading research institution, The Johns Hopkins University has the established expertise and capabilities to deliver this critical biomedical research initiative.
Generated 4/29/25, 1:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $319.9k | 7/25/24 |